Stage Matched Intervention to Increase Dual Method Use (PROTECT)
Primary Purpose
Contraception, Sexually Transmitted Diseases, Pregnancy
Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Individualized Intervention
Computer-based contraceptive information
Sponsored by
About this trial
This is an interventional prevention trial for Contraception focused on measuring prevention, behavior, risk reduction behavior
Eligibility Criteria
Inclusion Criteria:
- English-speaking
- Sexually active with a male partner in the past 6 months
- Desire to avoid conception for 24 months or more
High risk for unintended pregnancy or STI:
- Age less than 25
Age 25 and older with:
- History of unplanned pregnancy
- History of a sexually transmitted infection
- Inconsistent use of contraception
- Other factors felt to place a patient at above average risk for unplanned pregnancy or STI
Exclusion Criteria:
- currently using dual methods of contraception consistently and correctly.
- incompetent or unable to give consent;
- currently pregnant or desires pregnancy in the next 24 months.
Sites / Locations
- Women & Infants Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Individualized Intervention: stage-matched/tailored counseling
Control: Enhanced usual care counseling
Arm Description
Individualized Intervention is a computer-based, stage-matched, tailored intervention to promote the use of dual methods of contraception for STD and unplanned pregnancy prevention.
The Enhanced Usual Care arm was the control group. It provided computer-based information regarding contraceptive methods, but was not individualized or tailored to the participant stage of change.
Outcomes
Primary Outcome Measures
Behavioral: reported use of dual methods of contraception
Outcome: ANY use of dual methods of contraception.
Also evaluated consistent condom use.
Biological: incident sexually transmitted infection or unintended pregnancy
ANY sexually transmitted infection OR unintended pregnancy.
Secondary Outcome Measures
Secondary outcomes will include intermediate outcomes variables such as
Secondary outcomes: ANY sexually transmitted infection; unplanned pregnancy; incident infection with Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, or pelvic inflammatory disease.
changes in stage of change, processes of change, decisional balance, and self-efficacy.
Advancement through the stages of change, and changes in the processes of change, decisional balance, and self-efficacy.
Full Information
NCT ID
NCT00436306
First Posted
February 15, 2007
Last Updated
October 6, 2015
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1. Study Identification
Unique Protocol Identification Number
NCT00436306
Brief Title
Stage Matched Intervention to Increase Dual Method Use
Acronym
PROTECT
Official Title
Stage Matched Intervention to Increase Dual Method Use
Study Type
Interventional
2. Study Status
Record Verification Date
October 2015
Overall Recruitment Status
Completed
Study Start Date
October 1999 (undefined)
Primary Completion Date
December 2005 (Actual)
Study Completion Date
December 2005 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary purpose of Project PROTECT was to evaluate two different intervention approaches that encourage young women to use dual methods of contraception. The individualized intervention is a computer assisted, fully-tailored, interactive intervention based on the transtheoretical model of behavior change. This intervention was compared to an enhanced standard care intervention that provided computer-based, non-tailored information and advice regarding the use of contraceptive methods. The two primary outcomes of this trial include: 1) a behavioral outcome: the reported use of dual methods of contraception; and 2) a biological outcome: an incident or recurrent STI or unintended pregnancy. The hypotheses of this trial were: 1) the individualized intervention will result in a greater increase in dual contraceptive use than the standard care approach; and 2) the individualized intervention would result in greater protection against incident or recurrent cases of sexually transmitted infections and unplanned pregnancies.
Detailed Description
Protection from both sexually transmitted infections (STIs), human immunodeficiency virus (HIV), and unintended pregnancy can be achieved with the use of dual methods of contraception. This proposal was designed to develop, implement, and evaluate the impact of an innovative, computer-assisted stage-based individualized interactive intervention (Individualized Intervention) based on the transtheoretical compared to enhanced standard care counseling on the use of dual methods of contraception. Primary outcomes, including behavioral and biological outcomes, were assessed in this randomized clinical trial of 550 high-risk women. Participants were followed at 6 month intervals for 24 months with follow-up interviews to determine reported use of dual methods of contraception (behavioral outcome). Clinical examinations at 12 and 24 months and with new onset of symptoms assessed biological outcomes including incident or recurrent cases of STI and unintended pregnancy. Secondary outcomes included intermediate outcome variables such as changes in stage of change, processes of change, decisional balance, and self-efficacy. The primary hypotheses of this study were: 1. the Individualized Intervention will result in increased dual contraceptive use; 2. the Individualized Intervention will result in protection against new cases of STIs, re-infection with sexually transmitted organisms, and unplanned pregnancies; and 3. the Individualized Intervention will lead to the greatest changes in secondary outcome measures. If found to be effective, the stage-matched intervention has potential for widespread dissemination in schools, clinics, offices, and community centers to prevent STIs/HIV and unintended pregnancy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Contraception, Sexually Transmitted Diseases, Pregnancy
Keywords
prevention, behavior, risk reduction behavior
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
550 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Individualized Intervention: stage-matched/tailored counseling
Arm Type
Experimental
Arm Description
Individualized Intervention is a computer-based, stage-matched, tailored intervention to promote the use of dual methods of contraception for STD and unplanned pregnancy prevention.
Arm Title
Control: Enhanced usual care counseling
Arm Type
Placebo Comparator
Arm Description
The Enhanced Usual Care arm was the control group. It provided computer-based information regarding contraceptive methods, but was not individualized or tailored to the participant stage of change.
Intervention Type
Behavioral
Intervention Name(s)
Individualized Intervention
Intervention Description
Individualized Intervention is a computer-based, stage-matched, tailored intervention to promote the use of dual methods of contraception for STD and unplanned pregnancy prevention.
Intervention Type
Behavioral
Intervention Name(s)
Computer-based contraceptive information
Intervention Description
Contraceptive method information is provided on a computer.
Primary Outcome Measure Information:
Title
Behavioral: reported use of dual methods of contraception
Description
Outcome: ANY use of dual methods of contraception.
Also evaluated consistent condom use.
Time Frame
24 months
Title
Biological: incident sexually transmitted infection or unintended pregnancy
Description
ANY sexually transmitted infection OR unintended pregnancy.
Time Frame
24 months
Secondary Outcome Measure Information:
Title
Secondary outcomes will include intermediate outcomes variables such as
Description
Secondary outcomes: ANY sexually transmitted infection; unplanned pregnancy; incident infection with Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, or pelvic inflammatory disease.
Time Frame
24 months
Title
changes in stage of change, processes of change, decisional balance, and self-efficacy.
Description
Advancement through the stages of change, and changes in the processes of change, decisional balance, and self-efficacy.
Time Frame
24 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
13 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
English-speaking
Sexually active with a male partner in the past 6 months
Desire to avoid conception for 24 months or more
High risk for unintended pregnancy or STI:
Age less than 25
Age 25 and older with:
History of unplanned pregnancy
History of a sexually transmitted infection
Inconsistent use of contraception
Other factors felt to place a patient at above average risk for unplanned pregnancy or STI
Exclusion Criteria:
currently using dual methods of contraception consistently and correctly.
incompetent or unable to give consent;
currently pregnant or desires pregnancy in the next 24 months.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jeffrey F Peipert, MD, MPH
Organizational Affiliation
Washington University School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Women & Infants Hospital
City
Providence
State/Province
Rhode Island
ZIP/Postal Code
02905
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
17374567
Citation
Peipert J, Redding CA, Blume J, Allsworth JE, Iannuccillo K, Lozowski F, Mayer K, Morokoff PJ, Rossi JS. Design of a stage-matched intervention trial to increase dual method contraceptive use (Project PROTECT). Contemp Clin Trials. 2007 Sep;28(5):626-37. doi: 10.1016/j.cct.2007.01.012. Epub 2007 Feb 7.
Results Reference
background
PubMed Identifier
16394049
Citation
Matteson KA, Peipert JF, Allsworth J, Phipps MG, Redding CA. Unplanned pregnancy: does past experience influence the use of a contraceptive method? Obstet Gynecol. 2006 Jan;107(1):121-7. doi: 10.1097/01.AOG.0000192170.16746.ea.
Results Reference
result
PubMed Identifier
17714677
Citation
Peipert JF, Lapane KL, Allsworth JE, Redding CA, Blume JL, Lozowski F, Stein MD. Women at risk for sexually transmitted diseases: correlates of intercourse without barrier contraception. Am J Obstet Gynecol. 2007 Nov;197(5):474.e1-8. doi: 10.1016/j.ajog.2007.03.032. Epub 2007 Aug 21.
Results Reference
result
PubMed Identifier
18360319
Citation
Peipert JF, Lapane KL, Allsworth JE, Redding CA, Blume JD, Stein MD. Bacterial vaginosis, race, and sexually transmitted infections: does race modify the association? Sex Transm Dis. 2008 Apr;35(4):363-7. doi: 10.1097/OLQ.0b013e31815e4179.
Results Reference
result
PubMed Identifier
18313637
Citation
Krings KM, Matteson KA, Allsworth JE, Mathias E, Peipert JF. Contraceptive choice: how do oral contraceptive users differ from condom users and women who use no contraception? Am J Obstet Gynecol. 2008 May;198(5):e46-7. doi: 10.1016/j.ajog.2007.12.025. Epub 2008 Mar 7.
Results Reference
result
PubMed Identifier
18395692
Citation
Peipert JF, Redding CA, Blume JD, Allsworth JE, Matteson KA, Lozowski F, Mayer KH, Morokoff PJ, Rossi JS. Tailored intervention to increase dual-contraceptive method use: a randomized trial to reduce unintended pregnancies and sexually transmitted infections. Am J Obstet Gynecol. 2008 Jun;198(6):630.e1-8. doi: 10.1016/j.ajog.2008.01.038. Epub 2008 Apr 8.
Results Reference
result
PubMed Identifier
18468575
Citation
Kuroki LM, Allsworth JE, Redding CA, Blume JD, Peipert JF. Is a previous unplanned pregnancy a risk factor for a subsequent unplanned pregnancy? Am J Obstet Gynecol. 2008 Nov;199(5):517.e1-7. doi: 10.1016/j.ajog.2008.03.049. Epub 2008 May 12.
Results Reference
result
PubMed Identifier
19245303
Citation
Allsworth JE, Anand M, Redding CA, Peipert JF. Physical and sexual violence and incident sexually transmitted infections. J Womens Health (Larchmt). 2009 Apr;18(4):529-34. doi: 10.1089/jwh.2007.0757.
Results Reference
result
PubMed Identifier
21514555
Citation
Allsworth JE, Peipert JF. Severity of bacterial vaginosis and the risk of sexually transmitted infection. Am J Obstet Gynecol. 2011 Aug;205(2):113.e1-6. doi: 10.1016/j.ajog.2011.02.060. Epub 2011 Feb 27.
Results Reference
result
PubMed Identifier
21843690
Citation
Peipert JF, Zhao Q, Meints L, Peipert BJ, Redding CA, Allsworth JE. Adherence to dual-method contraceptive use. Contraception. 2011 Sep;84(3):252-8. doi: 10.1016/j.contraception.2011.01.023. Epub 2011 Apr 16.
Results Reference
result
Learn more about this trial
Stage Matched Intervention to Increase Dual Method Use
We'll reach out to this number within 24 hrs